In the 90s, early detection approaches such as prostate-specific antigen (PSA) blood were acknowledged to be effective in finding early-stage prostate cancer and are recommended among population at risk [13, 14], and the incidence rate of prostate cancer diagnosed in USA reached its peak [15]. This evidence concerns the gene KLK3 and prostate carcinoma.